[1] Tan W, Gao M, Liu N, et al . Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies[J]. Nutrients, 2015,7(10):8321-8334.
[2] 黄炳臣,林洁,李成山,等. 胆囊腺癌中VEGF和Ki67的表达及意义[J].齐齐哈尔医学院学报,2017,38(22):2634-2635.
[3] 乌云斯琴. 血清CA199和CA242、CA125检测用于胆囊癌患者诊断中的效果[J].中国医疗设备,2016,31(S1):139-140.
[4] 中华医学会外科学分会胆道外科学组. 胆囊癌诊断和治疗指南(2015版)[J].中华消化外科杂志,2015,14(11):881-890.
[5] Lorenzo Bermejo J, Boekstegers F, González Silos R, et al . Subtypes of Native American ancestry and leading causes of death: Mapuche ancestry-specific associations with gallbladder cancer risk in Chile[J]. PLOS Genetics, 2017,13(5):756-759.
[6] Ethun CG, Postlewait LM, Le N, et al . A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium[J]. Annals of Surgical Oncology, 2017,24(5):1343-1350.
[7] 吴红芳. 胆囊癌组织VEGF-C及TP表达水平与胆囊癌分化、浸润及转移的相关性研究[J].社区医学杂志,2016,14(13):19-21.
[8] 朱云楼,王巍. 术前血清CA125水平对于胆囊癌诊治的临床价值[J].复旦学报(医学版),2018,45(03):384-390.
[9] 马莉. VEGF及其受体的生物学特性及在肿瘤血管生成中的作用[J].中国优生与遗传杂志,2016,24(05):146-148. |
2021, Vol. 38 
